Patients with Relapsed/Refractory Hodgkin's Lymphoma Benefit from VTEPA ... Monthly Prescribing Reference Of patients with DLBCL, 70% had received prior salvage therapy with rituximab + ifosfamide, carboplatin, and etoposide (ICE) and 16% received other salvage regimens; 32 patients had received one cycle of rituximab + VTEPA and 12 patients, two cycles. ... |
